LLY R&D Expenses

Lilly (Eli) · R&D Expenses

LLY logo

LLY R&D Expenses

Latest reported$14.60B
LLY TTM R&D Expenses ($0.00 → $14.60B)
High-resolution chart · PNG

LLY r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Lilly (Eli) R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
14,596,200,000
14,113,200,000
13,337,200,000
12,558,200,000
11,826,600,000
11,201,800,000
10,990,600,000
10,530,800,000
10,205,800,000
9,851,100,000
9,313,400,000
8,746,600,000
8,140,400,000
7,565,800,000
7,190,800,000
7,154,300,000
7,056,700,000
6,929,800,000
6,991,800,000
6,870,400,000
6,630,500,000
6,365,700,000
6,085,700,000
5,829,100,000
5,744,600,000
5,756,600,000
5,595,000,000
5,467,400,000
5,367,400,000
5,236,200,000
5,113,200,000
5,132,600,000
5,191,700,000
5,192,800,000
5,343,600,000
5,321,000,000
5,217,400,000
5,281,200,000
5,243,900,000
5,237,500,000
5,144,500,000
4,978,100,000
4,796,400,000
4,537,900,000
4,637,700,000
4,663,600,000
4,733,600,000
5,023,300,000
5,157,500,000
5,292,500,000
5,531,300,000
5,519,000,000
5,484,400,000
5,474,700,000
5,278,100,000
5,170,300,000
5,108,400,000
5,048,300,000
5,020,800,000
5,103,600,000
5,042,500,000
4,969,100,000
4,884,200,000
4,662,800,000
4,565,100,000
4,418,300,000
4,326,500,000
4,169,100,000
4,000,000,000
3,911,100,000
3,840,900,000
3,735,200,000
3,626,700,000
3,529,600,000
3,486,700,000
3,391,100,000
3,302,300,000
3,222,700,000
3,129,300,000
3,081,200,000
3,076,500,000
3,064,100,000
3,025,500,000
2,921,100,000
2,824,900,000
2,746,700,000
2,691,100,000
2,695,600,000
2,608,900,000
2,467,200,000
2,350,200,000
2,214,500,000
2,173,100,000
2,176,100,000
2,149,300,000
2,164,900,000
2,204,200,000
2,222,400,000
2,235,100,000
2,190,300,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.